| Identification | More | [Name]
2,4-Dichloro-5-fluoropyrimidine | [CAS]
2927-71-1 | [Synonyms]
2,4-DICHLORO-5-FLUOROPYRIMIDINE
5-FLUORO-2,4-DICHLOROPYRIMIDINE
CHEMPACIFIC 37950
2,4-Dichloro-5-fluorouracil
5-Fluoro-2,4-dichloropyrimdine
2,6-DICHLORO-5-FLUORORACIL
2,4-Dichloro-5-Fluoropyrimidin
2,4-Dichloro-5-fluoropyrimidine99%
2,4-Dicloro-5-fluoro pyrimidin
2,4-Dichloro-5-fluoropyrimidine ,98% | [EINECS(EC#)]
625-810-7 | [Molecular Formula]
C4HCl2FN2 | [MDL Number]
MFCD00233551 | [Molecular Weight]
166.97 | [MOL File]
2927-71-1.mol |
| Chemical Properties | Back Directory | [Appearance]
Yellow to Orange Crystalline Solid | [Melting point ]
37-41 °C (lit.) | [Boiling point ]
80 °C / 16mmHg | [density ]
1.605±0.06 g/cm3(Predicted) | [Fp ]
223 °F
| [storage temp. ]
Inert atmosphere,2-8°C | [form ]
Powder or Crystalline Powder or Low Melting Solid | [pka]
-3.96±0.29(Predicted) | [color ]
White to pale brown | [Sensitive ]
Moisture Sensitive | [Detection Methods]
HPLC,NMR | [InChIKey]
WHPFEQUEHBULBW-UHFFFAOYSA-N | [CAS DataBase Reference]
2927-71-1(CAS DataBase Reference) | [Storage Precautions]
Moisture sensitive |
| Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36:Wear suitable protective clothing .
S37/39:Wear suitable gloves and eye/face protection . | [RIDADR ]
3261 | [WGK Germany ]
3
| [Hazard Note ]
Irritant | [HazardClass ]
8 | [HazardClass ]
IRRITANT | [PackingGroup ]
Ⅲ | [HS Code ]
29335900 |
| Hazard Information | Back Directory | [Chemical Properties]
2,4-Dichloro-5-fluoropyrimidine is Yellow to Orange Crystalline Solid
| [Uses]
2,4-Dichloro-5-fluoropyrimidine is used in the synthesis of two glucuronic derivatives of 5-fluorouracil as neoplasm inhibitors. It is used in the synthesis of two glucuronic derivatives of 5-fluorouracil as neoplasm inhibitors.
| [Flammability and Explosibility]
Notclassified |
|
|